# Italfarmaco clinical trials: 35 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 35 trials with Italfarmaco as lead sponsor, 4 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Italfarmaco: 35 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/italfarmaco

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 35
- Recruiting or not yet: 4
- Read on: November 19, 2026

## Trials

The 25 newest of 35, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 29, 2026 | NCT07376928 | Multicenter Prospective Real-world Observational Study to Evaluate the Effectiveness of Phlebotonics, as Conservative Therapy in a Cohort... | Italfarmaco | Observational | Completed | Hemorrhoidal Disease | 131 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07376928) |
| January 10, 2025 | NCT06769633 | Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old | Italfarmaco | Phase 2 | Recruiting | Duchenne Muscular Dystrophy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06769633) |
| December 16, 2024 | NCT06736223 | Pharmacokinetics, Safety and Tolerability of ITF2357 in Participants With Chronic Hepatic Impairment and With Normal Hepatic Function | Italfarmaco | Phase 1 | Completed | Hepatic Impairment | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06736223) |
| October 23, 2023 | NCT06093672 | Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera | Italfarmaco | Phase 3 | Recruiting | Polycythemia Vera | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06093672) |
| October 4, 2023 | NCT06067256 | A Multicentre, Prospective, Open-label, Non-comparative Study | Italfarmaco | Phase 4 | Unknown | Contraception | 228 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06067256) |
| July 6, 2023 | NCT05933057 | Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy | Italfarmaco | Phase 3 | Recruiting | Duchenne Muscular Dystrophy | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05933057) |
| May 16, 2023 | NCT05860114 | Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3) | Italfarmaco | Phase 1 | Completed | Drug Drug Interaction | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05860114) |
| May 6, 2023 | NCT05845567 | The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2) | Italfarmaco | Phase 1 | Completed | Drug Drug Interaction | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05845567) |
| August 8, 2022 | NCT05492318 | Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity | Italfarmaco | Phase 1 | Completed | Drug-Drug Interaction, Heathy Volunteer | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05492318) |
| June 15, 2021 | NCT04926727 | Prevalence And Burden Of Nausea And Vomiting In Pregnant Women | Italfarmaco | Observational | Unknown | Nausea Gravidarum, Vomiting of Pregnancy | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04926727) |
| March 29, 2021 | NCT04821063 | Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on... | Italfarmaco | Phase 1 | Completed | Duchenne and Becker Muscular Dystrophy, Polycytemia Vera | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04821063) |
| April 24, 2020 | NCT04362371 | Post Marketing Follow Up Study To Evaluate Performance Safety Quality of Menopausal Transition Women Treated With Ainara | Italfarmaco | Not applicable | Completed | Vaginal Disease | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04362371) |
| January 29, 2020 | NCT04245761 | Open Non-Comparative Study To Evaluate Administration Of a New Nutraceutical | Italfarmaco | Not applicable | Completed | Sleep Disorder | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04245761) |
| January 28, 2020 | NCT04245358 | Open Non-Comparative Clinical Trial Study To Evaluate The Performance And Safety Of Ainara® | Italfarmaco | Not applicable | Completed | Vaginal Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04245358) |
| January 28, 2020 | NCT04245293 | Clinical Trial Study To Evaluate The Performance And Safety Of Ainara® | Italfarmaco | Not applicable | Completed | Vaginal Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04245293) |
| December 14, 2017 | NCT03373968 | Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study | Italfarmaco | Phase 2/3 | Recruiting | Duchenne Muscular Dystrophy | 206 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03373968) |
| August 3, 2017 | NCT03238235 | Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy | Italfarmaco | Phase 2 | Completed | Becker Muscular Dystrophy | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03238235) |
| August 2, 2016 | NCT02851797 | Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy | Italfarmaco | Phase 3 | Completed | Duchenne Muscular Dystrophy | 179 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02851797) |
| April 10, 2014 | NCT02111044 | Phase II Study With ITF2984 in Acromegalic Patients | Italfarmaco | Phase 2 | Completed | Acromegaly | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02111044) |
| July 17, 2013 | NCT01901432 | A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera | Italfarmaco | Phase 1/2 | Completed | Polycythemia Vera | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01901432) |
| July 12, 2013 | NCT01897844 | A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers | Italfarmaco | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01897844) |
| June 7, 2013 | NCT01871844 | ITF2984 Repeated Doses Study in Healthy Volunteers | Italfarmaco | Phase 1 | Completed | Healthy Male Volunteers | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01871844) |
| January 7, 2013 | NCT01761968 | Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms | Italfarmaco | Phase 2 | Active not recruiting | Chronic Myeloproliferative Neoplasms | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01761968) |
| January 4, 2013 | NCT01761292 | A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD | Italfarmaco | Phase 1/2 | Completed | Duchenne Muscular Dystrophy (DMD) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01761292) |
| March 19, 2012 | NCT01557452 | Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis | Italfarmaco | Not applicable | Terminated | Juvenile Idiopathic Arthritis | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01557452) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 7 |
| Phase 1/2 | 5 |
| Phase 2 | 10 |
| Phase 2/3 | 1 |
| Phase 3 | 4 |
| Phase 4 | 1 |
| Not applicable | 5 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Terminated | 6 |
| Recruiting | 4 |
| Unknown | 2 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Muscular Dystrophy, Duchenne | 7 |
| Polycythemia Vera | 5 |
| Thrombocythemia, Essential | 3 |
| Primary Myelofibrosis | 3 |
| Vaginal Diseases | 3 |
| Myeloproliferative Disorders | 2 |
| Arthritis, Juvenile | 2 |
| Hodgkin Disease | 2 |
| Acromegaly | 1 |
| Multiple Myeloma | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Crohn Disease | 1 |
| Neoplasm Metastasis | 1 |
| Thromboembolism | 1 |
| Neoplasms | 1 |
| Sleep Wake Disorders | 1 |
| Rare Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Siding contractors in the United States](https://specstream.ai/data/businesses/siding-contractors/united-states)
- [Credit unions in the United States](https://specstream.ai/data/businesses/credit-unions/united-states)
- [Pediatric anesthesiology practices in the United States](https://specstream.ai/data/businesses/pediatric-anesthesiology-practices/united-states)
- [Banks in the United States](https://specstream.ai/data/businesses/banks/united-states)
- [Korean restaurants in the United States](https://specstream.ai/data/businesses/korean-restaurants/united-states)
- [Water softening equipment suppliers in the United States](https://specstream.ai/data/businesses/water-softening-equipment-suppliers/united-states)
